LIVE · 62 predictions across 31 open endpoints

The prediction market
for clinical trials

Submit predictions on trial endpoints. See where expert consensus sits. Track your accuracy as data readouts arrive.

Start predicting →Learn more
62
Active predictions
12
Registered users
31
Open endpoints

Live Consensus

Endpoints open for prediction

Browse all →

Datroway (datopotamab deruxtecan)

OncologyNCT05687266

HR for PFS in nonsquamous ITT population

Consensus median0.77Hazard Ratio
0.73 Hazard Ratio0.82 Hazard Ratio
2 predictionsReadout Dec 2027

R-DXd

OncologyNCT06161025PRIMARY

Hazard Ratio for Progression-Free Survival (PFS)

Consensus median0.52Hazard Ratio
0.38 Hazard Ratio0.62 Hazard Ratio
3 predictionsReadout TBD

Mezigdomide

OncologyNCT05552976PRIMARY

Hazard Ratio for Progression-Free Survival (PFS)

Consensus median0.58Hazard Ratio
0.48 Hazard Ratio0.72 Hazard Ratio
3 predictionsReadout TBD

Ivonescimab

OncologyNCT05899608PRIMARY

Hazard Ratio for Progression-Free Survival (PFS)

Consensus median0.79Hazard Ratio
0.7 Hazard Ratio0.83 Hazard Ratio
4 predictionsReadout TBD

Datroway (datopotamab deruxtecan)

OncologyNCT05687266

HR for OS in nonsquamous ITT population

Consensus median0.87Hazard Ratio
0.82 Hazard Ratio0.91 Hazard Ratio
2 predictionsReadout TBD

ONO-4578

OncologyNCT06256328

Hazard Ratio for Overall Survival (OS)

Consensus median0.8Hazard Ratio
0.72 Hazard Ratio0.95 Hazard Ratio
3 predictionsReadout TBD

Recent Activity

Latest predictions

DR

Dr. P. Marks predicted 62 % for Daraxonrasib

Objective Response Rate (ORR %)

12h agoHigh conviction
DR

Dr. P. Marks predicted 0.52 Hazard Ratio for Daraxonrasib

Hazard Ratio for Overall Survival (OS)

12h agoHigh conviction
DR

Dr. P. Marks predicted 0.48 Hazard Ratio for Daraxonrasib

Hazard Ratio for Progression-Free Survival (PFS)

13h agoHigh conviction
TR

Trial-Hunter updated to 0.58 Hazard Ratio for Daraxonrasib

Hazard Ratio for Progression-Free Survival (PFS)

13h agoHigh conviction
DR

Dr. P. Marks predicted 65 % for ONO-4578

Objective Response Rate (ORR %)

2d agoHigh conviction
RF

RFK-jnr predicted 53 % for ONO-4578

Objective Response Rate (ORR %)

2d agoLow conviction
TR

Trial-Hunter predicted 57 % for ONO-4578

Objective Response Rate (ORR %)

2d agoHigh conviction
DR

Dr. P. Marks predicted 0.65 Hazard Ratio for ONO-4578

Hazard Ratio for Progression-Free Survival (PFS)

2d agoHigh conviction
RF

RFK-jnr predicted 0.85 Hazard Ratio for ONO-4578

Hazard Ratio for Progression-Free Survival (PFS)

2d agoHigh conviction
TR

Trial-Hunter predicted 0.73 Hazard Ratio for ONO-4578

Hazard Ratio for Progression-Free Survival (PFS)

2d agoHigh conviction
DR

Dr. P. Marks predicted 0.72 Hazard Ratio for ONO-4578

Hazard Ratio for Overall Survival (OS)

3d agoHigh conviction
RF

RFK-jnr predicted 0.95 Hazard Ratio for ONO-4578

Hazard Ratio for Overall Survival (OS)

3d agoMed conviction
TR

Trial-Hunter predicted 0.8 Hazard Ratio for ONO-4578

Hazard Ratio for Overall Survival (OS)

3d agoLow conviction
DR

Dr. P. Marks predicted 0.55 Hazard Ratio for R-DXd

Hazard Ratio for Overall Survival (OS)

10d agoHigh conviction
DR

Dr. P. Marks predicted 0.38 Hazard Ratio for R-DXd

Hazard Ratio for Progression-Free Survival (PFS)

10d agoHigh conviction

Programs

Ivonescimab

Summit Therapeutics / Akeso

Featured2 trials

Daraxonrasib

Revolution Medicines, Inc.

Featured1 trial

Datroway (datopotamab deruxtecan)

AstraZeneca

Featured1 trial

Retevmo

Eli Lilly

Featured1 trial

BNT327 (pumitamig)

BioNTech SE

Featured1 trial

Setidegrasib

Astellas Pharma Global Development, Inc.

Featured3 trials
View all programs →+ Request a program

How It Works

Three steps to better signal

01
Find a trial
Search by drug name, dev code, company, or NCT number. Every active trial with open endpoints is on ProgramSignal.
02
Submit a prediction
Set your prediction for a specific endpoint — hazard ratio, response rate, or binary hit/miss — with your conviction level.
03
Track consensus
See where the community sits. Update your view as data emerges. Track your accuracy when readouts arrive.
Start predicting free →